ImmunologybioRxiv
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML
E. C. Sayitoglu, B. A. Luca, A. P. Boss…·M. G. Roncarolo
The paper identifies ICAM1 as a key factor in T cell killing of AML by analyzing transcriptional programs in AML and T cell interactions.